Search Results 351-360 of 16447 for 🙏🏻加☂️line:sammibaby☂️了解力曼RIMAN🍆减肥营养棒❓太保市瘦背減肥操⚾龟山区学生如何快速减肥🌂永安区鍛煉减肥最有效的方法⬛️冬瓜子有减肥功效嗎🎯减肥好的黑咖啡好👄韓國保養品牌台灣
Subjects who are experiencing recurrent CDI will undergo screening procedures. Subjects who meet eligibility criteria will be eligible to be enrolled in the ...
About this study. AIM III is a prospective, randomized, double-blinded, placebo controlled trial. The study is directly connected to IRB 08-008161 as a ...
About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ...
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients.
About this study. This study will enroll approximately 460 subjects, aged 55 or older, with a diagnosis of de novo AML (Acute Myeloid Leukemia) or AML ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...
Dr. LaRusso holds several U.S. patents for his work in the Cholangiopathies Lab and collaborates with other investigators on liver diseases.
About this study · Determine patient reported outcomes following total hip arthroplasty based on surgical approach. · Determine if the Forgotten Joint Score (FJS)- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.